Characterizing Spondyloarthritis With 68Ga-FAPI PET/CT
Spondyloarthritis, Axial Spondyloarthritis, Ankylosing Spondylitis
About this trial
This is an interventional diagnostic trial for Spondyloarthritis focused on measuring Spondyloarthritis, Axial Spondyloarthritis, Ankylosing Spondylitis, 68Ga-FAPI
Eligibility Criteria
Inclusion Criteria: A diagnosis of SpA according to the ASAS (Assessment of Spondyloarthritis International Society) classification criteria for SpA. Adult men or women 18 and ≤ 65 years of age at the time of signing the informed consent (ICF). participants who were able to provide informed consent (signed by participant or legal representative) and assent according to the guidelines of the Clinical Research Ethics Committee. Exclusion Criteria: Pregnancy; Breastfeeding; known allergy against FAPI; any medical condition that in the opinion of the investigator may significantly interfere with study compliance.
Sites / Locations
- The first affiliated hospital of Xiamen UniversityRecruiting
Arms of the Study
Arm 1
Experimental
Inject 68Ga-FAPI and then perform PET/CT scan.
Inject 68Ga-FAPI and then perform PET/CT scan